# PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)

> **NCT03070223** · PHASE3 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 602 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Pitavastatin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03070223
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-14
- **Primary completion:** 2023-08-21
- **Final completion:** 2023-08-21
- **Target enrollment:** 602 (ACTUAL)
- **Last updated:** 2024-10-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070223, "PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03070223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*